Fisher Asset Management LLC Sells 303 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Fisher Asset Management LLC cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 0.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 60,231 shares of the medical device company’s stock after selling 303 shares during the period. Fisher Asset Management LLC’s holdings in Cooper Companies were worth $6,646,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of Cooper Companies by 3.0% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock worth $682,738,000 after acquiring an additional 231,155 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares during the last quarter. Impax Asset Management Group plc boosted its holdings in Cooper Companies by 31.0% during the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock worth $205,511,000 after purchasing an additional 558,886 shares during the last quarter. Champlain Investment Partners LLC boosted its holdings in Cooper Companies by 8.0% during the third quarter. Champlain Investment Partners LLC now owns 1,818,345 shares of the medical device company’s stock worth $200,636,000 after purchasing an additional 134,875 shares during the last quarter. Finally, Swedbank AB boosted its holdings in Cooper Companies by 16.6% during the second quarter. Swedbank AB now owns 1,600,420 shares of the medical device company’s stock worth $139,717,000 after purchasing an additional 228,000 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Up 0.8 %

COO opened at $103.43 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The stock has a market cap of $20.60 billion, a price-to-earnings ratio of 57.46, a PEG ratio of 2.21 and a beta of 0.99. The Cooper Companies, Inc. has a twelve month low of $82.21 and a twelve month high of $112.38. The company’s 50-day moving average price is $105.45 and its two-hundred day moving average price is $98.48.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.84 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on COO shares. Morgan Stanley boosted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Wednesday. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Finally, Piper Sandler boosted their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $117.00.

Get Our Latest Research Report on Cooper Companies

Insider Activity at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. This represents a 24.94 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 256,373 shares of company stock worth $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.